FDA Investigator Brandy L Gillilan
Brandy L Gillilan has inspections in 1 countries as of 15 Sep 2023. Brandy L Gillilan has collaborated with a combined 1091 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby E Pelletier,
Aldo J Milone,
Alysia M Salonia,
Alyssa R Favro,
Andrew J Seaborn,
Antoinette L Chancey,
Ashley E Lewis,
Ashley M Whitehurst,
Barbara L Williams,
Brandy L Couillard,
Bryce H Thompson,
Carl A Huffman, III,
Christina Eggleston,
Christine L Williams,
Clinton V Giustra,
Daniel C Mccoham,
Daniel E Needham,
Davyd D Fytsyk Kravets,
Dean R Rugnetta,
Douglas S Joslin,
Edmund F Mrak, Jr,
Elizabeth P Mayer,
Erica B Raphael,
Gerard D Difiore,
Gordon,
Greg W Hites,
Isaac K Carney,
Jamie S Mathews,
John L Zaccone,
John M Seale,
John P Shelton,
John R Carlson,
Joseph Frost,
Joseph T Frost,
Karla J Youngberg,
Kathleen E Mcafoose,
Kathleen M Adams,
Kevin K Cole,
Kimberly L Wheeler,
Kimberly M White,
Liz M Otero,
Mark E Farrell,
Martin J Guardia,
Matthew D Silverman,
Milan S Mcgorty,
Nasser Yazdani,
Nicholas E Boyd,
Nichole B Murphy,
Osama A Khatib,
Paula M Laplant,
Perry H Gambrell,
Richard F Hapke,
Robert E Teel,
Rupa Pradhan,
Shannon A Dinardo,
Sharon Rhew,
Shawn G Lavene,
Slater K Bartlett,
State Agency,
Tania K Mercado,
Thomas H Jenkins,
Thomas O Morgan,
Troy R Petrillo
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more